linkedin
 
You Are On
Equity
Equity Analysis
News Analysis
Corporate Action
Corporate Info
Derivatives
Other Market
Research
 
 Board Meetings  
Commercial Syn Bags Ltd.
 
Source DateBoard Meeting DateDetails
26 May 202630 May 2026 Audited Results & Quarterly Results
30 Mar 202630 Mar 2026 Inter alia, to consider and approve the following businesses along with other routine businesses: 1. To consider and approve conversion of warrants into the equity shares of the Company which was issued to the promoter group subject to the depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company. 2. Other routine business items.
24 Mar 202628 Mar 2026 Inter alia, to consider and approve the following businesses along with other routine businesses: 1. To consider and approve conversion of warrants into the equity shares of the Company which was issued to the promoter group subject to the depositing the balance outstanding amount for conversion of warrants into the equity shares of the Company. 2. Other routine business items.
02 Feb 202605 Feb 2026 Quarterly Results
21 Jan 202624 Jan 2026 Inter alia, to consider the following businesses along with other routine businesses: 1. To consider and approve the expansion plan by setting up a new manufacturing unit of the Stepdown wholly owned subsidiary, Comsyn International Private Limited (formerly known as Erawat Vegcap Private Limited). 2. To consider and approve the expansion of Manufacturing capacity of various existing manufacturing units of Commercial Syn Bags Limited situated at Pithampur, District Dhar, Madhya Pradesh. 3. To consider and approve other matter incidental thereto.
03 Nov 202507 Nov 2025 Quarterly Results
01 Sep 202504 Sep 2025 Inter alia, to consider and approve:- 1. To consider and recommend final dividend, if any; 2. To consider and approve the Notice of the 41st Annual General Meeting for the Financial Year 2024-25 of the Company; 3. To consider and approve the Board Report of the Company for the Financial Year 2024-25; 4. To consider and approve other matter incidental thereto.
05 Aug 202508 Aug 2025 Quarterly Results
16 Jun 202519 Jun 2025 Inter alia, to consider the following businesses along with other routine businesses: 1. To consider and approve the appointment of an Additional Director under the Category of Non-Executive Independent Director; 2. To consider and approve the Notice of the 1/2025-26 Extra Ordinary General Meeting of the Company; 3. To consider and approve the alteration of Clause III of Memorandum of Association under Part (B) Ancillary to the attainment of the main objects of the company; 4. To Approve the cut-off date for eligibility to participate in the remote E-Voting and E- voting at 1/2025-26 Extra Ordinary General Meeting to be held through VC/OAVM; 5. To Appoint Scrutinizer for the process of remote E-voting as well as E-voting at the 1/2025-26 Extra Ordinary General Meeting of the Company; 6. To consider and approve other matter incidental thereto;
23 May 202530 May 2025 Quarterly Results & Audited Results
17 Mar 202520 Mar 2025 Inter alia, to consider and approved the matter related to allotment of upto 20,00,000 warrants of Rs. 72/- each convertible into equity shares of Rs. 10/- each at a premium of Rs. 62/- for every warrant to the Promoters and Promoter group of the company on preferential basis
10 Feb 202514 Feb 2025 Quarterly Results & Inter alia, to consider the following businesses along with other routine businesses: 1. To consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter/nine months ended on 31st December, 2024. 2. To take on record the Standalone and Consolidated Auditors Limited Review Report on financial results for the quarter/nine months ended on 31st December, 2024 3. To consider and approve the appointment of CS Sandeep Patel (M.No.: F13157) as the Company Secretary and Key Managerial Personnel of the Company. 4. Other Routine business items.
11 Dec 202414 Dec 2024 Issue Of Warrants inter-alia, consider and evaluate the following businesses: 1. Increase in Authorised Share Capital of the Company and Consequent Amendment in Capital Clause of the Memorandum of Association of the Company. 2. Proposal for raising funds by issue of warrants through all or any permissible modes or method, including private placement, preferential issue or such other modes as may be permitted under applicable law, subject to all such regulatory/statutory approvals and, if applicable, the approval of shareholders of the Company, and to approve ancillary actions in this regard, including determination of issue price, if any. 3. To consider and discuss any other business with permission of the Chairman
11 Nov 202414 Nov 2024 Quarterly Results
09 Aug 202414 Aug 2024 Quarterly Results
28 May 202430 May 2024 Audited Results (Revised)
22 May 202429 May 2024 Audited Results
07 Feb 202413 Feb 2024 Quarterly Results
03 Nov 202309 Nov 2023 Quarterly Results
23 Aug 202328 Aug 2023 A.G.M. & Inter alia, to consider and approve:- 1. The re-appointment of Mr. Anil Chaudhary (DIN: 00017913) Chairman & Managing Director of the company for further period of 3 (Three) years w.e.f., 20th February, 2024. 2. To consider and approve the Notice of the 39th Annual General Meeting for the Financial Year 2022-23 of the Company scheduled to be held on Wednesday 20th day of September, 2023; 3. To consider and approve the Board Report of the Company for the Financial Year 2022-23; 4. To consider and approve the Annual Book Closure for the purpose of the 39th Annual General Meeting. 5. Approval of the cut-off date for eligibility to participate in the remote E-Voting and E- voting at 39th Annual General Meeting to be held through VC/OAVM. 6. To Appoint Scrutinizer for the process of remote E-voting as well as E-voting at the 39th AGM of the Company. 7. To consider and approve other matter incidental thereto.
Page 1 of 3
Prev || Next
 
RMS | Policies & Procedures| PMLA | Disclaimer | Privacy Policy | Web Mail | Relationship | Investor Grievance
Career | Contact Us| KYC| PMS Risk Disclosure | Key Managerial Person | Basic Details | Process of Opening an Account | Process of Filing Complaint
Links to MCX | NCDEX |FMC | NCDEX CMID NCDEX-CO-04-00129 | MCX 10550 | FMC MCX: MCX/TCM/CORP/0008| FMC NCDEX : NCDEX/TCM/CORP/0274    
NSE: INB230914036 |NSE F & O INF230914036 |BSE: INB010914032 |BSE F & O: INF010914032 | CDSL: IN-DP-CDSL-335-2006 | OTC: INB200914032
Related Sites: Bombay Stock Exchange (BSE), Investor Protection, National Stock Exchange (NSE), Securities & Exchange Board of India (SEBI)
© Padmakshi 2009. All Rights Reserved. Designed || Developed & Content Powered By Accord Fintech Pvt. Ltd.